Valuation Charles River Laboratories International, Inc.

Stocks

Real-time Estimate Cboe BZX 12:02:28 23/09/2026 am IST			5-day change	1st Jan Change
288.20 ^USD	+3.30%		+6.03%	+45.05%

17/09	Charles River Laboratories International Introduces Rapid Cell Banking Programs with Next-Generation Sequencing Characterization	CI
17/09	Argus Research Adjusts Charles River Laboratories International PT to $330 From $250, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	13,320	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	32.89%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	15,432	14,950	14,557
Change	-	-36.28%	7.39%	-20.91%	3.29%	29.18%	-3.12%	-2.63%
P/E	49.4x	23.1x	25.9x	931x	-70x	76.3x	31.9x	27x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	4.42x	3.76x	3.34x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0x	1.5x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	3.41x	3.33x	3.16x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	3.95x	3.74x	3.46x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	15.3x	13.6x	12.3x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	18.8x	16.3x	14.5x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	48.9x	24.5x	30.5x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	2.05%	4.08%	3.28%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	3.659	8.751	10.34
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,911	4,001	4,209
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	1,007	1,096	1,181
EBIT ¹	742.1	834	838.8	805.9	793.9	820.5	914.4	1,003
Net income ¹	391	486.2	474.6	10.3	-144.3	162.5	430.8	476.7
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	2,112	1,631	1,237
Reference price ²	375.34	218.92	238.84	186.16	203.66	279.01	279.01	279.01
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	47,739	-	-
Announcement Date	16/02/22	22/02/23	14/02/24	19/02/25	18/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	76.26x	3.95x	15.33x	-.--%	1.33TCr
LONZA GROUP AG	32.07x	5.77x	17.28x	1.01%	4.67TCr
IQVIA HOLDINGS INC.	34.76x	3.35x	14.44x	-.--%	4.44TCr
REVOLUTION MEDICINES, INC.	-19.81x	213.44x	-21.53x	-.--%	4.13TCr
BEONE MEDICINES AG	47.9x	5.56x	30.41x	-.--%	4.16TCr
CELLTRION, INC.	27.45x	7.91x	20.36x	0.41%	3.01TCr
MEDPACE HOLDINGS, INC.	35.5x	5.83x	26.48x	-.--%	1.74TCr
EUROFINS SCIENTIFIC SE	26.02x	2.23x	9.67x	1.03%	1.55TCr
TEMPUS AI, INC.	-56.03x	9.2x	224.52x	-.--%	1.41TCr
Average	22.68x	28.58x	37.44x	0.27%	2.94TCr
Weighted average by Cap.	23.79x	37.90x	24.25x	0.29%